RNLS
Basic information
Region (hg38): 10:88273864-88584530
Previous symbols: [ "C10orf59" ]
Links
Phenotypes
GenCC
Source:
- cataract (Limited), mode of inheritance: AR
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (47 variants)
- not_provided (28 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the RNLS gene is commonly pathogenic or not. These statistics are base on transcript: NM_001031709.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 4 | |||||
missense | 48 | 56 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 48 | 10 | 3 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
RNLS | protein_coding | protein_coding | ENST00000331772 | 7 | 310667 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000380 | 0.829 | 125576 | 1 | 171 | 125748 | 0.000684 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.0182 | 185 | 186 | 0.996 | 0.00000922 | 2218 |
Missense in Polyphen | 64 | 61.667 | 1.0378 | 704 | ||
Synonymous | 0.508 | 64 | 69.4 | 0.922 | 0.00000345 | 664 |
Loss of Function | 1.38 | 11 | 17.2 | 0.640 | 7.93e-7 | 208 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00119 | 0.00118 |
Ashkenazi Jewish | 0.000298 | 0.000298 |
East Asian | 0.000276 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000397 | 0.000396 |
Middle Eastern | 0.000276 | 0.000272 |
South Asian | 0.00272 | 0.00268 |
Other | 0.000653 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the oxidation of the less abundant 1,2- dihydro-beta-NAD(P) and 1,6-dihydro-beta-NAD(P) to form beta- NAD(P)(+). The enzyme hormone is secreted by the kidney, and circulates in blood and modulates cardiac function and systemic blood pressure. Lowers blood pressure in vivo by decreasing cardiac contractility and heart rate and preventing a compensatory increase in peripheral vascular tone, suggesting a causal link to the increased plasma catecholamine and heightened cardiovascular risk. High concentrations of catecholamines activate plasma renalase and promotes its secretion and synthesis. {ECO:0000269|PubMed:15841207, ECO:0000269|PubMed:17385068, ECO:0000269|PubMed:25531177}.;
- Pathway
- Metabolism;Nicotinamide salvaging;Nicotinate metabolism;Metabolism of water-soluble vitamins and cofactors;Metabolism of vitamins and cofactors
(Consensus)
Recessive Scores
- pRec
- 0.115
Intolerance Scores
- loftool
- 0.234
- rvis_EVS
- 0.84
- rvis_percentile_EVS
- 88.3
Haploinsufficiency Scores
- pHI
- 0.0786
- hipred
- N
- hipred_score
- 0.144
- ghis
- 0.398
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0204
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Rnls
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- response to ischemia;negative regulation of heart rate;NAD biosynthesis via nicotinamide riboside salvage pathway;negative regulation of blood pressure;oxidation-reduction process;response to epinephrine;response to salt
- Cellular component
- extracellular region;extracellular space
- Molecular function
- oxidoreductase activity, acting on NAD(P)H;epinephrine binding;NADH binding;monoamine oxidase activity